NaturalNano
Receives Additional New Funding for 2010
ROCHESTER,
N.Y., December 7, 2009 -- NaturalNano, Inc. (NNAN; Frankfurt:N3N - News)
About NaturalNano, Inc. Acting CEO and President
James Wemett announced that NaturalNano has received funding sufficient to
support the Company’s core operating costs for most of 2010. “NaturalNano
has spent 2009 refocusing and re-establishing its core business and this new
financing is a major vote of confidence in the direction the Company is now
headed.” James Wemett continues, “NaturalNano has been fortunate to have the
support of its financial partners for the necessary re-positioning work
accomplished in 2009 and now we have additional support from a NYC firm to
expand not only our current technology but to continue our efforts to identify acquisitions opportunities that fit our capabilities
for improving products in the market.”
NaturalNano
continues to identify new applications that utilize its Halloysite Natural Tube
(HNT) technology. The Company holds a strong
patent portfolio and is working with a range of fortune 500 companies to improve
their product offerings. Wemett adds. “Our effort to provide free samples for
research and feasibility studies at Universities has been a major success. We have shipped samples for feasibility work around
the world through this program and NaturalNano expects to identify additional
uses for HNTs. The diverse uses of our
HNTs include improving the capture of cancer cells by using HNTs as part of a
novel cell capture technology in development at Cornell University
in the Lab of Dr. Michael King.”
“Wemett
also added that although the company is now listed on the Pink Sheets which
does not have SEC reporting obligations, (NNAN.OB is currently NNAN.PK) the
company is committed to maintaining its SEC reporting obligations and hopes to
be re listed on the OTC in 2010. In the meantime we will continue to
release information to our shareholders as we make progress in the New Year.
We thank our stockholders for their continued support and wish them a happy and
healthy Holiday Season.”
NaturalNano,
Inc. (NNAN - News; Frankfurt:N3N - News) is a materials science company focused on developing and
commercializing advanced nanocomposites. Based in Rochester, NY,
the Company is focused on additive technologies and processes, including its
proprietary Pleximer polymer additive that add value to industrial polymers,
plastics and composites, as well as consumer and industrial products.
NaturalNano holds and licenses over 25 patents and applications, as well as
proprietary know-how for extraction and separation processes, compositions, and
derivatives of Halloysite and other nanotubes. Visit www.naturalnano.com for more information.
Cautionary Statement Regarding Forward-Looking Statements: This press release may
contain forward-looking statements regarding future events and future
performance of NaturalNano that involve risks and uncertainties that could
materially affect actual results. This information is qualified in its
entirety by cautionary statements and risk factors disclosure contained in
certain of NaturalNano's filings with the Securities and Exchange Commission.
The most recent annual reports on Form 10-KSB and quarterly reports on Form
10-QSB filed by NaturalNano provide information about these factors, which may
be revised or supplemented in future reports to the SEC on those forms or on
Form 8-K. We caution investors not to place undue reliance on forward-looking
statements, and we do not undertake any obligation to update or otherwise revise
any forward-looking statements, whether as a result of new information, future
events, or other such factors that affect the subject of these statements,
except where expressly required by law.
# # #
Contact:
NaturalNano, Inc.
Jim Wemett
585-267-4848
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
|
